<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="EN">
  <front>
    <journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher></journal-meta>
    <article-meta><article-id pub-id-type="publisher-id">PONE-D-11-20614</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0030585</article-id><article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Medicine</subject>
          <subj-group>
            <subject>Clinical research design</subject>
          </subj-group>
          <subj-group>
            <subject>Epidemiology</subject>
          </subj-group>
          <subj-group>
            <subject>Oncology</subject>
            <subj-group>
              <subject>Cancer detection and diagnosis</subject>
            </subj-group>
            <subj-group>
              <subject>Cancer risk factors</subject>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Public health</subject>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline">
          <subject>Public Health and Epidemiology</subject>
          <subject>Oncology</subject>
        </subj-group>
      </article-categories><title-group><article-title>A Genetic Variant in miR-196a2 Increased Digestive System Cancer Risks: A Meta-Analysis of 15 Case-Control Studies</article-title><alt-title alt-title-type="running-head">miR-196a2 Variant Increased Digestive Cancer Risks</alt-title></title-group><contrib-group>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Guo</surname>
            <given-names>Jing</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Jin</surname>
            <given-names>Mingjuan</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Zhang</surname>
            <given-names>Mingwu</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Chen</surname>
            <given-names>Kun</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
      </contrib-group><aff id="aff1">          <addr-line>Department of Epidemiology and Health Statistics, School of Public Health, Zhejiang University, Hangzhou, Zhejiang, China</addr-line>       </aff><contrib-group>
        <contrib contrib-type="editor" xlink:type="simple">
          <name name-style="western">
            <surname>Christensen</surname>
            <given-names>Brock C.</given-names>
          </name>
          <role>Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group><aff id="edit1">Dartmouth College, United States of America</aff><author-notes>
        <corresp id="cor1">* E-mail: <email xlink:type="simple">ck@zju.edu.cn</email></corresp>
        <fn fn-type="con">
          <p>Conceived and designed the experiments: JG KC. Performed the experiments: JG MJ MZ. Analyzed the data: JG MZ. Contributed reagents/materials/analysis tools: MJ MZ. Wrote the paper: KC MJ.</p>
        </fn>
      <fn fn-type="conflict">
        <p>The authors have declared that no competing interests exist.</p>
      </fn></author-notes><pub-date pub-type="collection">
        <year>2012</year>
      </pub-date><pub-date pub-type="epub">
        <day>24</day>
        <month>1</month>
        <year>2012</year>
      </pub-date><volume>7</volume><issue>1</issue><elocation-id>e30585</elocation-id><history>
        <date date-type="received">
          <day>19</day>
          <month>10</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>22</day>
          <month>12</month>
          <year>2011</year>
        </date>
      </history><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2012</copyright-year><copyright-holder>Guo et al</copyright-holder><license><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract>
        <sec>
          <title>Background</title>
          <p>MicroRNAs (miRNAs) negatively regulate the gene expression and act as tumor suppressors or oncogenes in oncogenesis. The association between single nucleotide polymorphism (SNP) in miR-196a2 rs11614913 and the susceptibility of digestive system cancers was inconsistent in previous studies.</p>
        </sec>
        <sec>
          <title>Methodology/Principal Findings</title>
          <p>An updated meta-analysis based on 15 independent case-control studies consisting of 4999 cancer patients and 7606 controls was performed to address this association. It was found that miR-196a2 polymorphism significantly elevated the risks of digestive system cancers (CT vs. TT, OR = 1.25, 95% CI = 1.07–1.45; CC vs. TT, OR = 1.38, 95% CI = 1.13–1.67; CC/CT vs. TT, OR = 1.29, 95% CI = 1.10–1.50; CC vs. CT/TT, OR = 1.14, 95% CI = 1.01–1.30; C vs. T, OR = 1.15, 95% CI = 1.05–1.26). We also found that variant in miR-196a2 increased the susceptibility of colorectal cancer (CRC) (CT vs. TT, OR = 1.23, 95% CI = 1.04–1.44; CC vs. TT, OR = 1.32, 95% CI = 1.08–1.61; CC/CT vs. TT, OR = 1.25, 95% CI = 1.07–1.46; C vs. T, OR = 1.15, 95% CI = 1.05–1.28), while the association in recessive model (CC vs. CT/TT, OR = 1.16, 95% CI = 0.98–1.38) showed a marginal significance. Additionally, significant association between miR-196a2 polymorphism and increased risk of hepatocellular cancer (HCC) was detected. By stratifying tumors on the basis of site of origin, source of controls, ethnicity and allele frequency in controls, elevated cancer risks were observed.</p>
        </sec>
        <sec>
          <title>Conclusion/Significance</title>
          <p>Our findings suggest the significant association between miR-196a2 polymorphism and increased susceptibility of digestive system cancers, especially of CRC, HCC and Asians. Besides, C allele may contribute to increased digestive cancer risks.</p>
        </sec>
      </abstract><funding-group><funding-statement>This study was supported by the National Natural Science Foundation of China (No. 81072356). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts>
        <page-count count="7"/>
      </counts></article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>Introduction</title>
      <p>MicroRNAs (miRNAs) are endogenous, small non-coding and have a length of 18–25 nucleotides RNAs. miRNAs can interact with messenger RNAs (mRNAs) by binding to 3′ un-translated regions (UTRs) and lead to the degradation or translational repression of mRNAs. Studies revealed that miRNAs played key roles in various biological processes including cell growth regulation, differentiation, apoptosis and tumorigenesis <xref ref-type="bibr" rid="pone.0030585-Bartel1">[1]</xref>, <xref ref-type="bibr" rid="pone.0030585-Bartel2">[2]</xref>, <xref ref-type="bibr" rid="pone.0030585-Landi1">[3]</xref>. miRNAs regulate approximately 30% of human genes and exhibit a remarkable contribution to carcinogenesis <xref ref-type="bibr" rid="pone.0030585-Bartel2">[2]</xref>, <xref ref-type="bibr" rid="pone.0030585-Carthew1">[4]</xref>. Aberrant modulation of specific miRNAs was considered to be a crucial event of diverse diseases including cancers <xref ref-type="bibr" rid="pone.0030585-Kent1">[5]</xref> although the detailed process of miRNAs expression and mutation are still ambiguous. Moreover, some studies detected that miRNAs participated in the etiology, progression and prognosis of cancers, such as non-small cell lung cancer <xref ref-type="bibr" rid="pone.0030585-Hu1">[6]</xref> and hepatocellular carcinoma <xref ref-type="bibr" rid="pone.0030585-Pineau1">[7]</xref>. Several possible mechanisms, including genetic and epigenetic alternations, have been proposed. SNPs in miRNAs are marked as novel genetic variations which may modify the cancer susceptibilities <xref ref-type="bibr" rid="pone.0030585-Chen1">[8]</xref>. Genetic variant in miR-196a2 had been demonstrated to be associated with some cancer risks, but different studies showed conflicting associations. Meta-analysis on breast cancer, lung cancer and other cancers revealed that rs11614913 was a functional SNP and had potential ability to modify the cancer risks <xref ref-type="bibr" rid="pone.0030585-Chu1">[9]</xref>, <xref ref-type="bibr" rid="pone.0030585-Gao1">[10]</xref>, <xref ref-type="bibr" rid="pone.0030585-Tian1">[11]</xref>, <xref ref-type="bibr" rid="pone.0030585-Wang1">[12]</xref>, <xref ref-type="bibr" rid="pone.0030585-Xu1">[13]</xref>.</p>
      <p>As we know, the above-referenced meta-analysis included gastric cancer (GC), HCC and other digestive cancers for the SNP in miR-196a2. However, by the limitation of inadequate publications, they did not calculate pooled ORs of digestive system cancers comprehensively. To improve the efficiency of meta-analysis on digestive cancers and reduce the potential between-study heterogeneity which might derive from various cancers in diverse systems, we focused on digestive system cancers only and added more recent publications on CRC <xref ref-type="bibr" rid="pone.0030585-Chen2">[14]</xref>, <xref ref-type="bibr" rid="pone.0030585-Zhan1">[15]</xref>, <xref ref-type="bibr" rid="pone.0030585-Zhu1">[16]</xref> and HCC <xref ref-type="bibr" rid="pone.0030585-Akkiz1">[17]</xref> in this study. We also contacted the authors to request for genotype frequencies about oral cavity squamous cancer (OSCC) and pharynx squamous cancer (PSCC) <xref ref-type="bibr" rid="pone.0030585-Christensen1">[18]</xref>, <xref ref-type="bibr" rid="pone.0030585-Liu1">[19]</xref> which were not shown in published articles. In addition, an unpublished case-control study on CRC which was performed by Mingwu Zhang et al at the Molecular Epidemiology Laboratory in Zhejiang University School of Medicine was collected. Overall, 9 datasets from 7 studies (including 2875 cases with digestive cancers and 5556 controls) which had not been studied in previous meta-analysis were additionally included in our study. And we performed this meta-analysis focusing on the following issues: (a) What is the association between miR-196a2 polymorphism and the susceptibility of digestive system cancers, especially of colorectal cancer? (b) Would changes in tumor sites, demographic characteristics and other factors transform this association significantly?</p>
    </sec>
    <sec id="s2" sec-type="materials|methods">
      <title>Materials and Methods</title>
      <sec id="s2a">
        <title>Identification of eligible studies</title>
        <p>A systematic search in PubMed was conducted using a retrieving query formulation “(microrna 196a2 OR rs11614913) polymorphisms cancer” (last search updated on 20 Aug, 2011). We also searched references in published articles and reviews on this topic in PubMed. Eligible studies were selected according to the following explicit inclusion criteria: (a) Study was designed using the methodology of a case-control study. (b) The association between miR-196a2 polymorphism and digestive system cancer risks was explored. (c) There was sufficient data for the computation of odds ratios and corresponding 95% confidence intervals (ORs, 95% CIs). (d) Cases with carcinomas were diagnosed by histopathology. Moreover, we also contacted some researchers to request unpublished study outcomes and detailed datasets for pooled calculation (<xref ref-type="fig" rid="pone-0030585-g001">Figure 1</xref>).</p>
        <fig id="pone-0030585-g001" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0030585.g001</object-id>
          <label>Figure 1</label>
          <caption>
            <title>Flow diagram of studies identification.</title>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0030585.g001" xlink:type="simple"/>
        </fig>
      </sec>
      <sec id="s2b">
        <title>Data extraction</title>
        <p>Two investigators (Guo and Jin) screened titles, abstracts and full texts independently using a standardized screening guide. Data extraction was carried out independently after the concealment of authors, journals, supporting organizations and funds to avoid investigators' bias. After data abstraction, discrepancies and differences were resolved by consensus and discussion.</p>
        <p>Characteristics of enrolled studies were assigned to the structured form (<xref ref-type="table" rid="pone-0030585-t001">Table 1</xref>), including first author's name, publication time, study country origin, ethnicity, cancer type, source of controls, genotyping method, matched criteria between cases and controls, sample size, C allele frequency in controls (<xref ref-type="supplementary-material" rid="pone.0030585.s003">Table S1</xref>), genotype frequency distribution and quality scores.</p>
        <table-wrap id="pone-0030585-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0030585.t001</object-id><label>Table 1</label><caption>
            <title>Characteristics of eligible studies in meta-analysis.</title>
          </caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pone-0030585-t001-1" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0030585.t001" xlink:type="simple"/><table>
            <colgroup span="1">
              <col align="left" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <td align="left" colspan="1" rowspan="1">First author</td>
                <td align="left" colspan="1" rowspan="1">Publication</td>
                <td align="left" colspan="1" rowspan="1">Country</td>
                <td align="left" colspan="1" rowspan="1">Ethnicity</td>
                <td align="left" colspan="1" rowspan="1">Control</td>
                <td align="left" colspan="1" rowspan="1">Cancer</td>
                <td align="left" colspan="1" rowspan="1">Genotyping</td>
                <td align="left" colspan="1" rowspan="1">Matching criteria</td>
                <td align="left" colspan="1" rowspan="1">Quality</td>
                <td align="left" colspan="1" rowspan="1">HWE</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">Year</td>
                <td align="left" colspan="1" rowspan="1">origin</td>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">source</td>
                <td align="left" colspan="1" rowspan="1">type</td>
                <td align="left" colspan="1" rowspan="1">method</td>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">score</td>
                <td align="left" colspan="1" rowspan="1"/>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" colspan="1" rowspan="1">Zhan</td>
                <td align="left" colspan="1" rowspan="1">2011</td>
                <td align="left" colspan="1" rowspan="1">China</td>
                <td align="left" colspan="1" rowspan="1">Asian</td>
                <td align="left" colspan="1" rowspan="1">HB</td>
                <td align="left" colspan="1" rowspan="1">CRC</td>
                <td align="left" colspan="1" rowspan="1">PCR-RFLP</td>
                <td align="left" colspan="1" rowspan="1">age/sex</td>
                <td align="left" colspan="1" rowspan="1">6.5</td>
                <td align="left" colspan="1" rowspan="1">Y</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Chen</td>
                <td align="left" colspan="1" rowspan="1">2010</td>
                <td align="left" colspan="1" rowspan="1">China</td>
                <td align="left" colspan="1" rowspan="1">Asian</td>
                <td align="left" colspan="1" rowspan="1">HB</td>
                <td align="left" colspan="1" rowspan="1">CRC</td>
                <td align="left" colspan="1" rowspan="1">PCR-LDR</td>
                <td align="left" colspan="1" rowspan="1">age/sex</td>
                <td align="left" colspan="1" rowspan="1">7</td>
                <td align="left" colspan="1" rowspan="1">Y</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Zhu</td>
                <td align="left" colspan="1" rowspan="1">2011</td>
                <td align="left" colspan="1" rowspan="1">China</td>
                <td align="left" colspan="1" rowspan="1">Asian</td>
                <td align="left" colspan="1" rowspan="1">HB</td>
                <td align="left" colspan="1" rowspan="1">CRC</td>
                <td align="left" colspan="1" rowspan="1">TaqManSNP</td>
                <td align="left" colspan="1" rowspan="1">age/sex</td>
                <td align="left" colspan="1" rowspan="1">7.5</td>
                <td align="left" colspan="1" rowspan="1">Y</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Zhang</td>
                <td align="left" colspan="1" rowspan="1">2011<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0030585.e001" xlink:type="simple"/></inline-formula></td>
                <td align="left" colspan="1" rowspan="1">China</td>
                <td align="left" colspan="1" rowspan="1">Asian</td>
                <td align="left" colspan="1" rowspan="1">PB</td>
                <td align="left" colspan="1" rowspan="1">CRC</td>
                <td align="left" colspan="1" rowspan="1">PCR-RFLP</td>
                <td align="left" colspan="1" rowspan="1">age/sex</td>
                <td align="left" colspan="1" rowspan="1">7.5</td>
                <td align="left" colspan="1" rowspan="1">N</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Wang</td>
                <td align="left" colspan="1" rowspan="1">2010</td>
                <td align="left" colspan="1" rowspan="1">China</td>
                <td align="left" colspan="1" rowspan="1">Asian</td>
                <td align="left" colspan="1" rowspan="1">PB</td>
                <td align="left" colspan="1" rowspan="1">ESCC</td>
                <td align="left" colspan="1" rowspan="1">SNaPshot</td>
                <td align="left" colspan="1" rowspan="1">age/sex/area</td>
                <td align="left" colspan="1" rowspan="1">7</td>
                <td align="left" colspan="1" rowspan="1">Y</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Srivastava</td>
                <td align="left" colspan="1" rowspan="1">2010</td>
                <td align="left" colspan="1" rowspan="1">Indian</td>
                <td align="left" colspan="1" rowspan="1">Caucasian</td>
                <td align="left" colspan="1" rowspan="1">PB</td>
                <td align="left" colspan="1" rowspan="1">GBC</td>
                <td align="left" colspan="1" rowspan="1">PCR-RFLP</td>
                <td align="left" colspan="1" rowspan="1">age/sex</td>
                <td align="left" colspan="1" rowspan="1">6.5</td>
                <td align="left" colspan="1" rowspan="1">Y</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Okubo</td>
                <td align="left" colspan="1" rowspan="1">2010</td>
                <td align="left" colspan="1" rowspan="1">Japan</td>
                <td align="left" colspan="1" rowspan="1">Asian</td>
                <td align="left" colspan="1" rowspan="1">HB</td>
                <td align="left" colspan="1" rowspan="1">GC</td>
                <td align="left" colspan="1" rowspan="1">PCR-RFLP</td>
                <td align="left" colspan="1" rowspan="1">UK</td>
                <td align="left" colspan="1" rowspan="1">6.5</td>
                <td align="left" colspan="1" rowspan="1">Y</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Peng</td>
                <td align="left" colspan="1" rowspan="1">2010</td>
                <td align="left" colspan="1" rowspan="1">China</td>
                <td align="left" colspan="1" rowspan="1">Asian</td>
                <td align="left" colspan="1" rowspan="1">HB</td>
                <td align="left" colspan="1" rowspan="1">GC</td>
                <td align="left" colspan="1" rowspan="1">PCR-RFLP</td>
                <td align="left" colspan="1" rowspan="1">age/sex</td>
                <td align="left" colspan="1" rowspan="1">6.5</td>
                <td align="left" colspan="1" rowspan="1">Y</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Li</td>
                <td align="left" colspan="1" rowspan="1">2010</td>
                <td align="left" colspan="1" rowspan="1">China</td>
                <td align="left" colspan="1" rowspan="1">Asian</td>
                <td align="left" colspan="1" rowspan="1">HB</td>
                <td align="left" colspan="1" rowspan="1">HCC</td>
                <td align="left" colspan="1" rowspan="1">PCR-RFLP</td>
                <td align="left" colspan="1" rowspan="1">UK</td>
                <td align="left" colspan="1" rowspan="1">6</td>
                <td align="left" colspan="1" rowspan="1">Y</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Qi♣</td>
                <td align="left" colspan="1" rowspan="1">2010</td>
                <td align="left" colspan="1" rowspan="1">China</td>
                <td align="left" colspan="1" rowspan="1">Asian</td>
                <td align="left" colspan="1" rowspan="1">HB</td>
                <td align="left" colspan="1" rowspan="1">HCC</td>
                <td align="left" colspan="1" rowspan="1">PCR-LDR</td>
                <td align="left" colspan="1" rowspan="1">UK</td>
                <td align="left" colspan="1" rowspan="1">6.5</td>
                <td align="left" colspan="1" rowspan="1">Y</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Akkiz</td>
                <td align="left" colspan="1" rowspan="1">2011</td>
                <td align="left" colspan="1" rowspan="1">Turkey</td>
                <td align="left" colspan="1" rowspan="1">Caucasian</td>
                <td align="left" colspan="1" rowspan="1">HB</td>
                <td align="left" colspan="1" rowspan="1">HCC</td>
                <td align="left" colspan="1" rowspan="1">PCR-RFLP</td>
                <td align="left" colspan="1" rowspan="1">age/sex/smoke</td>
                <td align="left" colspan="1" rowspan="1">7</td>
                <td align="left" colspan="1" rowspan="1">Y</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Christensen</td>
                <td align="left" colspan="1" rowspan="1">2010</td>
                <td align="left" colspan="1" rowspan="1">USA</td>
                <td align="left" colspan="1" rowspan="1">Caucasian</td>
                <td align="left" colspan="1" rowspan="1">PB</td>
                <td align="left" colspan="1" rowspan="1">OSCC</td>
                <td align="left" colspan="1" rowspan="1">TaqManSNP</td>
                <td align="left" colspan="1" rowspan="1">age/sex/residence</td>
                <td align="left" colspan="1" rowspan="1">8.5</td>
                <td align="left" colspan="1" rowspan="1">Y</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Liu</td>
                <td align="left" colspan="1" rowspan="1">2010</td>
                <td align="left" colspan="1" rowspan="1">USA</td>
                <td align="left" colspan="1" rowspan="1">Caucasian</td>
                <td align="left" colspan="1" rowspan="1">HB</td>
                <td align="left" colspan="1" rowspan="1">OSCC</td>
                <td align="left" colspan="1" rowspan="1">PCR-RFLP</td>
                <td align="left" colspan="1" rowspan="1">age/sex</td>
                <td align="left" colspan="1" rowspan="1">7.5</td>
                <td align="left" colspan="1" rowspan="1">Y</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Christensen</td>
                <td align="left" colspan="1" rowspan="1">2010</td>
                <td align="left" colspan="1" rowspan="1">USA</td>
                <td align="left" colspan="1" rowspan="1">Caucasian</td>
                <td align="left" colspan="1" rowspan="1">PB</td>
                <td align="left" colspan="1" rowspan="1">PSCC</td>
                <td align="left" colspan="1" rowspan="1">TaqManSNP</td>
                <td align="left" colspan="1" rowspan="1">age/sex/residence</td>
                <td align="left" colspan="1" rowspan="1">8.5</td>
                <td align="left" colspan="1" rowspan="1">Y</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Liu</td>
                <td align="left" colspan="1" rowspan="1">2010</td>
                <td align="left" colspan="1" rowspan="1">USA</td>
                <td align="left" colspan="1" rowspan="1">Caucasian</td>
                <td align="left" colspan="1" rowspan="1">HB</td>
                <td align="left" colspan="1" rowspan="1">PSCC</td>
                <td align="left" colspan="1" rowspan="1">PCR-RFLP</td>
                <td align="left" colspan="1" rowspan="1">age/sex</td>
                <td align="left" colspan="1" rowspan="1">7.5</td>
                <td align="left" colspan="1" rowspan="1">Y</td>
              </tr>
            </tbody>
          </table></alternatives><table-wrap-foot>
            <fn id="nt101">
              <label/>
              <p>CRC: colorectal cancer; ESCC: esophageal squamous cell carcinoma; GBC: gallbladder cancer; GC: gastric cancer; HCC: hepatocellular cancer; OSCC: oral cavity squamous cancer; PSCC: pharynx squamous cancer; UK: unknown; HWE: Hardy-Weinberg equilibrium; Y: genotype frequency distribution agreed to HWE in controls; N: genotype frequency distribution disagreed to HWE in controls; PCR-RFLP: polymerase chain reaction-restriction fragment length polymorphism; PCR-LDR: polymerase chain reaction-ligation detection reaction; HB: hospital-based; PB: population-based; <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0030585.e002" xlink:type="simple"/></inline-formula>: study year; Qi♣: HBV patients without HCC were controls and HBV patients with HCC were cases in the study of Qi.</p>
            </fn>
          </table-wrap-foot></table-wrap>
      </sec>
      <sec id="s2c">
        <title>Methodological quality assessment</title>
        <p>Three reviewers (Guo, Jin and Zhang) independently evaluated the quality of selected studies by scoring according to a set of predetermined criteria (<xref ref-type="supplementary-material" rid="pone.0030585.s004">Table S2</xref>) which was extracted and modified from previous studies <xref ref-type="bibr" rid="pone.0030585-Thakkinstian1">[20]</xref>, <xref ref-type="bibr" rid="pone.0030585-Camargo1">[21]</xref>, <xref ref-type="bibr" rid="pone.0030585-Gao2">[22]</xref>. Quality scores ranged from 0 to 10 and the studies with higher scores presented better quality. Disagreements were resolved by discussion.</p>
      </sec>
      <sec id="s2d">
        <title>Statistical analysis</title>
        <p>Crude ORs and corresponding 95%CIs were calculated to investigate the association strength between miR-196a2 polymorphism and the susceptibility of digestive system cancers. Pooled ORs were obtained from combination of single studies by heterozygote comparison (CT vs. TT), homozygote comparison (CC vs. TT), dominant and recessive models (CC/CT vs. TT, CC vs. CT/TT), allelic comparison (C vs. T) respectively. We used chi-square-based Q-test <xref ref-type="bibr" rid="pone.0030585-Higgins1">[23]</xref> and the I<sup>2</sup> index <xref ref-type="bibr" rid="pone.0030585-Higgins2">[24]</xref> to check the heterogeneity among different studies. When Q-test showed the existence of notable heterogeneity (P-value less than 0.10 and/or I<sup>2</sup> index more than 50%,), we used the random-effects model (DerSimonian and Laird method) <xref ref-type="bibr" rid="pone.0030585-DerSimonian1">[25]</xref>; otherwise, the fixed-effects model (Mantel and Haenszel method) was conducted <xref ref-type="bibr" rid="pone.0030585-Mantel1">[26]</xref>.</p>
        <p>Stratification by tumor site, source of controls, ethnicity and allele frequency in controls was conducted. All cancers were categorized into two groups: digestive tract cancer and digestive gland cancer. Eligible studies were classified into population-based and hospital-based according to control source. The subjects were classified by ethnicity into Caucasian group and Asian group. We also classified the selected studies into C&gt;T (C allele frequency more than T allele frequency) group and C≤T (C allele frequency less than or equivalent to T allele frequency) group by allele frequency in controls.</p>
        <p>Hardy-Weinberg equilibrium (HWE) in control population was judged by the chi-square test. P-value less than 0.05 was considered to be a state of disequilibrium. Publication bias was diagnosed with Egger's linear regression method <xref ref-type="bibr" rid="pone.0030585-Hayashino1">[27]</xref>, <xref ref-type="bibr" rid="pone.0030585-Peters1">[28]</xref> and funnel plot. The P-value less than 0.05 in Egger's linear regression indicated the presence of potential publication bias. The standard error of logarithm for OR was plotted against its OR in funnel plot. Begg's funnel plot was also plotted to detect the publication bias and influence of individual study on pooled OR. Log OR was plotted versus standard error of Log OR for each included study in Begg's funnel plot <xref ref-type="bibr" rid="pone.0030585-Begg1">[29]</xref>. And asymmetric or incomplete funnel-shaped plots demonstrated publication bias also. In the one-way sensitivity analysis, we excluded one single study each time, and the new pooled results could reflect the influence of that deleted study to the overall summary OR.</p>
        <p>The frequency distributions of C allele in Asians and Caucasians were compared using chi-square test. All statistical analysis was implemented with SAS 9.2 software (SAS Institute Inc., Cary, NC, USA), STATA 11.0 (STATA Corp, College Station, Texas) and RevMan 5.1 (<ext-link ext-link-type="uri" xlink:href="http://ims.cochrane.org/revman/download" xlink:type="simple">http://ims.cochrane.org/revman/download</ext-link>). All P-values were two-sided.</p>
      </sec>
    </sec>
    <sec id="s3">
      <title>Results</title>
      <sec id="s3a">
        <title>Studies characteristics</title>
        <p>13 eligible studies including 12 published studies <xref ref-type="bibr" rid="pone.0030585-Chen2">[14]</xref>, <xref ref-type="bibr" rid="pone.0030585-Zhan1">[15]</xref>, <xref ref-type="bibr" rid="pone.0030585-Zhu1">[16]</xref>, <xref ref-type="bibr" rid="pone.0030585-Akkiz1">[17]</xref>, <xref ref-type="bibr" rid="pone.0030585-Christensen1">[18]</xref>, <xref ref-type="bibr" rid="pone.0030585-Liu1">[19]</xref>, <xref ref-type="bibr" rid="pone.0030585-Li1">[30]</xref>, <xref ref-type="bibr" rid="pone.0030585-Okubo1">[31]</xref>, <xref ref-type="bibr" rid="pone.0030585-Peng1">[32]</xref>, <xref ref-type="bibr" rid="pone.0030585-Qi1">[33]</xref>, <xref ref-type="bibr" rid="pone.0030585-Srivastava1">[34]</xref>, <xref ref-type="bibr" rid="pone.0030585-Wang2">[35]</xref> and 1 unpublished one were collected in this meta-analysis according to the inclusion criteria. Characteristics of these studies were presented in <xref ref-type="table" rid="pone-0030585-t001">Table 1</xref> and the genotype frequency distribution was shown in <xref ref-type="supplementary-material" rid="pone.0030585.s003">Table S1</xref>.</p>
        <p>Among studies on head and neck squamous cell carcinoma (HNSCC, which included oral, pharyngeal and laryngeal cancers) <xref ref-type="bibr" rid="pone.0030585-Christensen1">[18]</xref>, <xref ref-type="bibr" rid="pone.0030585-Liu1">[19]</xref>, laryngeal cancer in respiratory system was not used. We considered patients with oral cancer and pharyngeal cancer as separate groups and pooled them into quantitative analysis independently. Therefore, this meta-analysis employed 15 separate case-control studies, including 4999 cases and 7606 controls, for the polymorphism of miR-196a2.</p>
        <p>12 studies were matched for age, sex and/or residence, smoking, alcohol consumption <xref ref-type="bibr" rid="pone.0030585-Chen2">[14]</xref>, <xref ref-type="bibr" rid="pone.0030585-Zhan1">[15]</xref>, <xref ref-type="bibr" rid="pone.0030585-Zhu1">[16]</xref>, <xref ref-type="bibr" rid="pone.0030585-Akkiz1">[17]</xref>, <xref ref-type="bibr" rid="pone.0030585-Christensen1">[18]</xref>, <xref ref-type="bibr" rid="pone.0030585-Liu1">[19]</xref>, <xref ref-type="bibr" rid="pone.0030585-Peng1">[32]</xref>, <xref ref-type="bibr" rid="pone.0030585-Srivastava1">[34]</xref>, <xref ref-type="bibr" rid="pone.0030585-Wang2">[35]</xref>; 9 studies collected Asians as subjects and the other 6 investigated Caucasians; C allele frequency of controls was the minor allele frequency (MAF) in 7 studies and T allele frequency was MAF in the 8 studies remained; controls in 10 studies were hospital-based and controls of the other studies were population-based; 11 studies described alimentary tract cancers and 4 studies focused on tumors in digestive glands. To dilute the potential confounding bias of HBV infection in the study of Qi et al <xref ref-type="bibr" rid="pone.0030585-Qi1">[33]</xref>, we kept the HBV patients without HCC as controls and the HBV patients with HCC as cases.</p>
        <p>Genotypes in all studies were detected with genetic DNA from blood samples using 4 genotyping methods totally. 13 out of 15 studies checked genotypes for quality control. Genotype distribution of controls in all studies was consistent with HWE, except for Mingwu Zhang's study on CRC.</p>
      </sec>
      <sec id="s3b">
        <title>Publication bias</title>
        <p>We found no significant evidence of publication bias (P-value&gt;0.05) in any comparison model using Egger's linear regression method. Furthermore, the shape of funnel plot for the allele contrast (C vs. T) showed approximately symmetric and inverted funnel-shaped (<xref ref-type="supplementary-material" rid="pone.0030585.s001">Figure S1</xref>). Begge's funnel plot (C vs. T) did not reveal any remarkable asymmetry in the distribution of scattered points (<xref ref-type="fig" rid="pone-0030585-g002">Figure 2</xref>). Among all studies included, Wang's study on ESCC <xref ref-type="bibr" rid="pone.0030585-Wang2">[35]</xref> and Liu's on PSCC <xref ref-type="bibr" rid="pone.0030585-Liu1">[19]</xref> deviated from other symmetrically distributed studies. When these two studies were deleted, I<sup>2</sup> decreased from 63% (Ph = 0.0005) to 42% (Ph = 0.05). While the summary OR for allele contrast (C vs. T) still kept significant (OR = 1.15, 95%CI = 1.06–1.25), and this result was similar to pooled OR without deletion of any study (OR = 1.15, 95%CI = 1.05–1.26).</p>
        <fig id="pone-0030585-g002" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0030585.g002</object-id>
          <label>Figure 2</label>
          <caption>
            <title>Begg's funnel plot of publication bias.</title>
            <p>Log OR is plotted versus standard error of Log OR for each included study. Every circle dot represents a separate study for the indicated association by allele contrast (C over T). Wang's study on ESCC (upper dot) and Liu's study on PSCC (lower dot) locate outside of pseudo 95% CI limits evidently.</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0030585.g002" xlink:type="simple"/>
        </fig>
      </sec>
      <sec id="s3c">
        <title>Test of heterogeneity</title>
        <p>Between-study heterogeneities and corresponding quantitative degrees in all comparisons and subgroups, were shown in <xref ref-type="supplementary-material" rid="pone.0030585.s005">Table S3</xref>. After stratification, the heterogeneities decreased obviously in the subgroups of CRC, GC, digestive gland, HCC, hospital-based controls, and C≤T group (Ph&gt;0.10 and I<sup>2</sup>&lt;50% in most genetic comparisons).</p>
      </sec>
      <sec id="s3d">
        <title>Sensitivity analysis</title>
        <p>We deleted one single study from the overall pooled analysis each time to check the influence of the removed data set to the overall ORs. Two studies (Wang (ESCC) <xref ref-type="bibr" rid="pone.0030585-Wang2">[35]</xref> and Liu (PSCC) <xref ref-type="bibr" rid="pone.0030585-Liu1">[19]</xref>) changed the between-study heterogeneities materially in heterozygote comparison and recessive model respectively. After the deletion of anyone of the two studies mentioned, the heterogeneity vanished, while the association still kept significant (<xref ref-type="supplementary-material" rid="pone.0030585.s006">Table S4</xref>).</p>
      </sec>
      <sec id="s3e">
        <title>Meta-analysis results</title>
        <p>The association strength between miR-196a2 polymorphism and the susceptibility for digestive system cancers are shown in <xref ref-type="table" rid="pone-0030585-t002">Table 2</xref>. Overall, there was a statistically increased risk of digestive system cancers in every genetic comparison (CT vs. TT, OR = 1.25, 95% CI = 1.07–1.45; CC vs. TT, OR = 1.38, 95% CI = 1.13–1.67; CC/CT vs. TT, OR = 1.29, 95% CI = 1.10–1.50; CC vs. CT/TT, OR = 1.14, 95% CI = 1.01–1.30; C vs. T, OR = 1.15, 95% CI = 1.05–1.26).</p>
        <table-wrap id="pone-0030585-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0030585.t002</object-id><label>Table 2</label><caption>
            <title>Pooled ORs and 95%CIs of stratified meta-analysis.</title>
          </caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pone-0030585-t002-2" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0030585.t002" xlink:type="simple"/><table>
            <colgroup span="1">
              <col align="left" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <td align="left" colspan="1" rowspan="1">Stratification</td>
                <td align="left" colspan="1" rowspan="1">N</td>
                <td align="left" colspan="1" rowspan="1">CT vs. TT</td>
                <td align="left" colspan="1" rowspan="1">CC vs. TT</td>
                <td align="left" colspan="1" rowspan="1">CC/CT vs. TT</td>
                <td align="left" colspan="1" rowspan="1">CC vs. CT/TT</td>
                <td align="left" colspan="1" rowspan="1">C VS. T</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">OR (95% CI)</td>
                <td align="left" colspan="1" rowspan="1">OR (95% CI)</td>
                <td align="left" colspan="1" rowspan="1">OR (95% CI)</td>
                <td align="left" colspan="1" rowspan="1">OR (95% CI)</td>
                <td align="left" colspan="1" rowspan="1">OR (95% CI)</td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" colspan="1" rowspan="1">Digestive cancers</td>
                <td align="left" colspan="1" rowspan="1">15</td>
                <td align="left" colspan="1" rowspan="1">1.25(1.07–1.45)<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">1.38(1.13–1.67)<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">1.29(1.10–1.50)<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">1.14(1.01–1.30)<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">1.15(1.05–1.26)<xref ref-type="table-fn" rid="nt103">*</xref></td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Tumor site</td>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1"/>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Alimentary tract</td>
                <td align="left" colspan="1" rowspan="1">11</td>
                <td align="left" colspan="1" rowspan="1">1.23(1.03–1.48)<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">1.32(1.05–1.65)<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">1.26(1.04–1.51)<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">1.12(0.98–1.28)</td>
                <td align="left" colspan="1" rowspan="1">1.13(1.02–1.25)<xref ref-type="table-fn" rid="nt103">*</xref></td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">CRC</td>
                <td align="left" colspan="1" rowspan="1">4</td>
                <td align="left" colspan="1" rowspan="1">1.23(1.04–1.44)<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">1.32(1.08–1.61)<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">1.25(1.07–1.46)<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">1.16(0.98–1.38)</td>
                <td align="left" colspan="1" rowspan="1">1.15(1.05–1.28)<xref ref-type="table-fn" rid="nt103">*</xref></td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">GC</td>
                <td align="left" colspan="1" rowspan="1">2</td>
                <td align="left" colspan="1" rowspan="1">1.07(0.85–1.34)</td>
                <td align="left" colspan="1" rowspan="1">1.24(0.94–1.65)</td>
                <td align="left" colspan="1" rowspan="1">1.12(0.90–1.39)</td>
                <td align="left" colspan="1" rowspan="1">1.22(0.96–1.55)</td>
                <td align="left" colspan="1" rowspan="1">1.12(0.98–1.28)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">ESCC</td>
                <td align="left" colspan="1" rowspan="1">1</td>
                <td align="left" colspan="1" rowspan="1">2.42(1.66–3.55)<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">2.67(1.77–4.04)<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">2.51(1.74–3.62)<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">1.35(1.02–1.78)<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">1.45(1.21–1.75)<xref ref-type="table-fn" rid="nt103">*</xref></td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">OSCC</td>
                <td align="left" colspan="1" rowspan="1">2</td>
                <td align="left" colspan="1" rowspan="1">1.00(0.47–2.13)</td>
                <td align="left" colspan="1" rowspan="1">1.07(0.64–1.80)</td>
                <td align="left" colspan="1" rowspan="1">1.03(0.53–1.98)</td>
                <td align="left" colspan="1" rowspan="1">1.05(0.87–1.29)</td>
                <td align="left" colspan="1" rowspan="1">1.04(0.91–1.19)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">PSCC</td>
                <td align="left" colspan="1" rowspan="1">2</td>
                <td align="left" colspan="1" rowspan="1">1.35(0.79–2.32)</td>
                <td align="left" colspan="1" rowspan="1">1.33(0.49–3.60)</td>
                <td align="left" colspan="1" rowspan="1">1.36(0.66–2.83)</td>
                <td align="left" colspan="1" rowspan="1">1.00(0.59–1.68)</td>
                <td align="left" colspan="1" rowspan="1">1.09(0.72–1.63)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Digestive gland</td>
                <td align="left" colspan="1" rowspan="1">4</td>
                <td align="left" colspan="1" rowspan="1">1.30(1.02–1.65)<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">1.64(1.24–2.17)<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">1.38(1.10–1.74)<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">1.24(0.85–1.79)</td>
                <td align="left" colspan="1" rowspan="1">1.20(0.96–1.51)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">HCC</td>
                <td align="left" colspan="1" rowspan="1">3</td>
                <td align="left" colspan="1" rowspan="1">1.27(0.99–1.64)</td>
                <td align="left" colspan="1" rowspan="1">1.79(1.31–2.43)<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">1.41(1.11–1.79)<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">1.49(1.16–1.91)<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">1.32(1.14–1.54)<xref ref-type="table-fn" rid="nt103">*</xref></td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">GBC</td>
                <td align="left" colspan="1" rowspan="1">1</td>
                <td align="left" colspan="1" rowspan="1">1.50(0.72–3.12)</td>
                <td align="left" colspan="1" rowspan="1">1.04(0.51–2.11)</td>
                <td align="left" colspan="1" rowspan="1">1.20(0.60–2.41)</td>
                <td align="left" colspan="1" rowspan="1">0.74(0.51–1.07)</td>
                <td align="left" colspan="1" rowspan="1">0.85(0.64–1.15)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Source of control</td>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1"/>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">HB</td>
                <td align="left" colspan="1" rowspan="1">10</td>
                <td align="left" colspan="1" rowspan="1">1.21(1.08–1.36)<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">1.37(1.12–1.66)<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">1.24(1.12–1.38)<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">1.18(1.00–1.40)</td>
                <td align="left" colspan="1" rowspan="1">1.16(1.05–1.28)<xref ref-type="table-fn" rid="nt103">*</xref></td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">PB</td>
                <td align="left" colspan="1" rowspan="1">5</td>
                <td align="left" colspan="1" rowspan="1">1.37(0.84–2.22)</td>
                <td align="left" colspan="1" rowspan="1">1.39(0.84, 2.30)</td>
                <td align="left" colspan="1" rowspan="1">1.36(0.85–2.19)</td>
                <td align="left" colspan="1" rowspan="1">1.09(0.94–1.27)</td>
                <td align="left" colspan="1" rowspan="1">1.11(0.91–1.36)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Ethnicity</td>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1"/>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Asian</td>
                <td align="left" colspan="1" rowspan="1">9</td>
                <td align="left" colspan="1" rowspan="1">1.26(1.05–1.50)<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">1.47(1.18–1.82)<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">1.32(1.10–1.57)<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">1.25(1.11–1.40)<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">1.20(1.10–1.31)<xref ref-type="table-fn" rid="nt103">*</xref></td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Caucasian</td>
                <td align="left" colspan="1" rowspan="1">6</td>
                <td align="left" colspan="1" rowspan="1">1.26(0.93–1.72)</td>
                <td align="left" colspan="1" rowspan="1">1.26(0.88–1.80)</td>
                <td align="left" colspan="1" rowspan="1">1.25(0.91–1.72)</td>
                <td align="left" colspan="1" rowspan="1">1.02(0.83–1.27)</td>
                <td align="left" colspan="1" rowspan="1">1.07(0.91–1.26)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Allele frequency in controls</td>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1"/>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">C&gt;T</td>
                <td align="left" colspan="1" rowspan="1">8</td>
                <td align="left" colspan="1" rowspan="1">1.36(1.00–1.85)</td>
                <td align="left" colspan="1" rowspan="1">1.45(1.01–2.07)<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">1.39(1.02–1.90)<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">1.11(0.91–1.36)</td>
                <td align="left" colspan="1" rowspan="1">1.15(0.98–1.34)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">C≤T</td>
                <td align="left" colspan="1" rowspan="1">7</td>
                <td align="left" colspan="1" rowspan="1">1.18(1.04–1.34)<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">1.33(1.14–1.55)<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">1.22(1.08–1.37)<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">1.20(1.05–1.37)<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">1.15(1.07–1.24)<xref ref-type="table-fn" rid="nt103">*</xref></td>
              </tr>
            </tbody>
          </table></alternatives><table-wrap-foot>
            <fn id="nt102">
              <label/>
              <p>N: involved studies' number; CT vs. TT: Heterozygote comparison; CC vs. TT: Homozygote comparison; CC/CT vs. TT: Dominant model; CC vs. CT/TT: Recessive model; C VS. T: Allele contrast; Random model was chosen for data pooling when P-value&lt;0.10 and/or I<sup>2</sup>&gt;50%; otherwise fixed model was used;</p>
            </fn>
            <fn id="nt103">
              <label/>
              <p>*: OR had statistical significance with corresponding 95%CI not including 1.</p>
            </fn>
          </table-wrap-foot></table-wrap>
        <p>Tumor site, source of controls, ethnicity and allele frequency in controls were taken into consideration for subgroup analysis. The forest plots of dominant models (CC/CT vs. TT) in different subgroups were shown in <xref ref-type="supplementary-material" rid="pone.0030585.s002">Figure S2</xref>. Comparing with genotype TT, heterozygote CT (OR = 1.23, 95% CI = 1.03–1.48), homozygote CC (OR = 1.32, 95% CI = 1.05–1.65), combination of CT/CC (OR = 1.26, 95% CI = 1.04–1.51) predominantly increased incidences of cancers in alimentary tract. And we also found that C allele carriers had more risks of digestive tract cancers (C vs. T, OR = 1.13, 95% CI = 1.02–1.25), but no significant result was observed in recessive model (CC vs. CT/TT, OR = 1.12, 95% CI = 0.98–1.28).</p>
        <p>Significant association between SNP rs11614913 and increased risks of digestive gland cancers was found in three genetic models (CT vs. TT, OR = 1.30, 95% CI = 1.02–1.65; CC vs. TT, OR = 1.64, 95% CI = 1.24–2.17; CC/CT vs. TT, OR = 1.38, 95% CI = 1.10–1.74), except for recessive model (CC vs. TT, OR = 1.24, 95% CI = 0.85–1.79) and allele contrast (C vs. T, OR = 1.20, 95% CI = 0.96–1.51). Additionally, we demonstrated that this locus polymorphism was significantly linked to higher risks for CRC (CT vs. TT, OR = 1.23, 95% CI = 1.04–1.44; CC vs. TT, OR = 1.32, 95% CI = 1.08–1.61; CC/CT vs. TT, OR = 1.25, 95% CI = 1.07–1.46; C vs. T, OR = 1.15, 95% CI = 1.05–1.28), but a marginal significance was found in recessive model (CC vs. CT/TT, OR = 1.16, 95% CI = 0.98–1.38). We also observed increased susceptibility of HCC in homozygote comparison (OR = 1.79, 95% CI = 1.31–2.43), dominant model (OR = 1.41, 95% CI = 1.11–1.79), recessive model (OR = 1.49, 95% CI = 1.16–1.91) and allele contrast (OR = 1.32, 95% CI = 1.14–1.54). We just found a marginal significance in homozygote comparison (OR = 1.27, 95% CI = 0.99–1.64) in HCC study. Compared with CRC and HCC, no significant associations were found in GC, OSCC and PSCC.</p>
        <p>With consideration of control source, studies with hospital-based controls showed elevated risks in four genetic comparisons (CT vs. TT, OR = 1.21, 95% CI = 1.08–1.36; CC vs. TT, OR = 1.37, 95% CI = 1.12–1.66; CC/CT vs. TT, OR = 1.24, 95% CI = 1.12–1.38; C vs. T, OR = 1.16, 95% CI = 1.05–1.28) and an edge effect was obtained in recessive model (OR = 1.18, 95% CI = 1.00–1.40). However, studies with population-based controls presented no significant association.</p>
        <p>For the Asian group, every genetic comparison produced significantly increased risks (CT vs. TT, OR = 1.26, 95% CI = 1.05–1.50; CC vs. TT, OR = 1.47, 95% CI = 1.18–1.82; CC/CT vs. TT, OR = 1.32, 95% CI = 1.10–1.57; CC vs. CT/TT, OR = 1.25, 95% CI = 1.11–1.40; C vs. T, OR = 1.20, 95% CI = 1.10–1.31) while no significant associations were detected in Caucasian group.</p>
        <p>In the subgroup of C&gt;T, remarkably elevated cancer risks were found in homozygote comparison (OR = 1.45, 95% CI = 1.01–2.07) and dominant model (OR = 1.39, 95% CI = 1.02–1.90). While we did not find significant associations among heterozygote comparison (OR = 1.36, 95% CI = 1.00–1.85), recessive model (OR = 1.11, 95% CI = 0.91–1.36) and allele contrast (OR = 1.15, 95% CI = 0.98–1.34). Meanwhile, significant association between miR-196a2 polymorphism and increased risk of digestive system cancer was also found in the C≤T group (CT vs. TT, OR = 1.18, 95% CI = 1.04–1.34; CC vs. TT, OR = 1.33, 95% CI = 1.14–1.55; CC/CT vs. TT, OR = 1.22, 95% CI = 1.08–1.37; CC vs. CT/TT, OR = 1.20, 95% CI = 1.05–1.37; C vs. T, OR = 1.15, 95% CI = 1.07–1.24).</p>
        <p>When we compared C allele frequency in Asians with that in Caucasians, Zhang's study on CRC was excluded due to its HWE disequilibrium in controls. C allele frequency of miR-196a2 ranged from 0.419 to 0.754 across Asian and Caucasian controls. In Asian controls, C allele frequency accounted for 45.60% which was significantly lower than that in Caucasian controls (59.90%,χ<sup>2</sup> = 222.32, P&lt;0.0001 ). A former study reported a parallel observation <xref ref-type="bibr" rid="pone.0030585-Chu1">[9]</xref>.</p>
        <p>The MOOSE Checklist for our study was shown as <xref ref-type="supplementary-material" rid="pone.0030585.s007">Table S5</xref>.</p>
      </sec>
    </sec>
    <sec id="s4">
      <title>Discussion</title>
      <p>miRNAs participate in diverse biological processes and is regarded as a key factor in oncogenesis. SNP in miR-196a2 rs11614913 was thought to be implicated in altered expression and function of mature miRNAs, thus contributed to modified cancer risks. Many studies demonstrated variant in rs11614913 was significantly associated with the susceptibility of various cancers. Hong et al. found that carriers with TC/CC genotype of miR-196a2 had higher risks for non-small cell lung cancer (NSCLC) comparing with TT carriers <xref ref-type="bibr" rid="pone.0030585-Hong1">[36]</xref>. Comparing with TT genotype, Hu et al. observed that CC or CC/CT genotypes significantly increased breast cancer risks <xref ref-type="bibr" rid="pone.0030585-Hu2">[37]</xref>. Similar results were also found in glioma <xref ref-type="bibr" rid="pone.0030585-Dou1">[38]</xref>, prostatic cancer <xref ref-type="bibr" rid="pone.0030585-George1">[39]</xref> and other kinds of cancers.</p>
      <p>Further more, SNPs in miRNAs can occasionally disturb the gene or protein expression and result in pathogenicity <xref ref-type="bibr" rid="pone.0030585-Yu1">[40]</xref>. Zhan and his colleagues reported that the expression levels of miR-196a in CC and CC/CT genotypes were higher than those in TT genotype in CRC <xref ref-type="bibr" rid="pone.0030585-Zhan1">[15]</xref>. Li et al. also found that CC and CC/CT genotypes increased the expression level of miR-196a in HCC patients with HBV infection comparing with TT genotype <xref ref-type="bibr" rid="pone.0030585-Li1">[30]</xref>. Hu et al. found that the expression level of miR-196a in CC genotype carriers was significantly lower than that in CT or TT carriers with NSCLC <xref ref-type="bibr" rid="pone.0030585-Hu1">[6]</xref>. Additionally, compared with CT/TT genotype, CC genotype of miR-196a2 predominantly decreased the survival time of NSCLC patients in Hu's study <xref ref-type="bibr" rid="pone.0030585-Hu1">[6]</xref>. Thus Hu and his colleagues proposed the genetic variant in this locus to be a prognostic biomarker for NSCLC.</p>
      <p>Our study showed that the presence of C allele significantly increased the risk of digestive system cancers with the comparison to T allele. This finding indicates that the genetic variant in miR-196a2 may crucially modify the susceptibility of digestive system cancers. Previous meta-analysis which described cancers locating in multiple systems of organism supported our finding <xref ref-type="bibr" rid="pone.0030585-Chu1">[9]</xref>, <xref ref-type="bibr" rid="pone.0030585-Xu1">[13]</xref>.</p>
      <p>We found that miR-196a2 polymorphism, in stratified analysis by cancer site, was statistically related with elevated cancer risks in the alimentary tract group and digestive gland group. Moreover, significantly increased risks were found in CRC and HCC. However, we did not observe any significant association between the genetic variant and the susceptibility of GC, OSCC and PSCC. There are some possibilities for this discrepancy among tumor sites. Firstly, the tissue specificity leads to different cancer susceptibilities in different tissues. Secondly, the relative small amount of eligible studies in stratified analysis might induce significant/insignificant association by chance due to insufficient statistical power <xref ref-type="bibr" rid="pone.0030585-Tapia1">[41]</xref>. Two previous meta-analysis reported insignificant association between miR-196a2 polymorphism and HCC risks <xref ref-type="bibr" rid="pone.0030585-Chu1">[9]</xref>, <xref ref-type="bibr" rid="pone.0030585-Xu1">[13]</xref>, which was inconsistent to our finding. We infer that fewer included studies and the neglect of HBV infection in controls might lead to insignificant results in previous meta-analysis.</p>
      <p>In the subgroup of ethnicity, we found significant association between miR-196a2 polymorphism and increased risks of digestive system cancers in Asians but not in Caucasians. A former meta-analysis reported a parallel observation to us <xref ref-type="bibr" rid="pone.0030585-Chu1">[9]</xref>. Inconsistency between the two ethnicities can be explained by the possibility that different ethnic groups live with multiple life styles and environmental factors and thus yield diverse gene-environment interactions <xref ref-type="bibr" rid="pone.0030585-Dick1">[42]</xref>. And different populations carry different genotype and/or allele frequencies of this locus polymorphism and may lead to various degrees of cancer susceptibility <xref ref-type="bibr" rid="pone.0030585-Gao3">[43]</xref>. Relative small sample size in Caucasians might cause the inconspicuousness also.</p>
      <p>The majority (70%, 7/10) of studies with hospital-based controls recruited Asians as tested subjects and we found significantly increased risks in this subgroup. While most (60%, 3/5) studies with population-based controls investigated Caucasians and we did not found any significant results in this subgroup. So the mentioned ethnic interpretations are available to the inconsistency in control source stratification. And the possible selection bias in controls with different matched criteria and sample size may also be the reasons. Chu's meta-analysis study also reported significantly increased cancer risks in Asians but not in Caucasians <xref ref-type="bibr" rid="pone.0030585-Chu1">[9]</xref>.</p>
      <p>Disagreements in the stratification of allele frequency in controls might attribute to above interpretations for ethnic effect to some extent.</p>
      <p>Some advantages can be highlighted in our study. On one hand, this meta-analysis shed light on the association between miR-196a2 polymorphism and increased risks of digestive system cancers, CRC and HCC comprehensively and systematically. On the other hand, the inclusion of an unpublished study on CRC and the collection of unpublished genotype frequency of OSCC and PSCC strengthened the power and persuasion of our inference. Further more, all included studies had acceptable quality (scored at least 6). Limitations of this study should be noticed at the same time. Firstly, genetic factors, tumor biological characteristics and their interactions with environmental factors produce evident influences to the cancer susceptibility and tumorigenesis. Different cancers have different risk factors and diverse sensitivities to them. For instance, Heliobacter pylori infections and smoking may increase the incidence of gastric cancer. And hepatitis B, C virus infections and exposure of aflatoxin in food are risk to liver cancer <xref ref-type="bibr" rid="pone.0030585-Wallace1">[44]</xref>. Studies included in this meta-analysis contained various cancers, ethnic populations and nations, and multifactor such as gender, age, lifestyle, culture barriers, access to health care and exposure to pathogens and carcinogens were disparate. While lacking of individual information inhibited us from controlling the possible confounding factors which might be caused by the inconsistencies above. We also could not perform more precise calculation of adjusted ORs and further analysis of potential gene-environment interactions. Secondly, included researches did not cover all kinds of digestive system cancers, such as pancreatic cancer. And thirdly, language bias might derive from the screened references of English documents only.</p>
      <p>In summary, this meta-analysis indicated that miR-196a2 rs11614913 polymorphism may increase the susceptibility of digestive system cancers, especially of CRC and HCC. SNP in this locus may considerably act as a candidate of biomarker for cancer screening, diagnosis and therapy in the future. To confirm our findings, further well-designed studies with large sample size in diverse ethnic populations, more types of digestive system cancers along with tissue-specific biochemical, functional and expressional characteristics are required.</p>
    </sec>
    <sec id="s5">
      <title>Supporting Information</title>
      <supplementary-material id="pone.0030585.s001" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pone.0030585.s001" xlink:type="simple">
        <label>Figure S1</label>
        <caption>
          <p><bold>Funnel plot of publication bias.</bold> The standard error of log (OR) is plotted versus OR for each study. Each square represents a separate study for the indicated association by allele contrast (C vs. T). The dotted line in blue indicates the estimated OR.</p>
          <p>(TIF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pone.0030585.s002" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pone.0030585.s002" xlink:type="simple">
        <label>Figure S2</label>
        <caption>
          <p><bold>Forest plots of dominant model (CC/CT vs. TT) in different subgroups.</bold> The squares and horizontal lines correspond to OR and 95% CI of specific study, and the area of squares reflects study weight (inverse of the variance). The diamond represents the pooled OR and its 95% CI.</p>
          <p>(TIF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pone.0030585.s003" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pone.0030585.s003" xlink:type="simple">
        <label>Table S1</label>
        <caption>
          <p>
            <bold>Genotype frequency distribution of studies included.</bold>
          </p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pone.0030585.s004" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pone.0030585.s004" xlink:type="simple">
        <label>Table S2</label>
        <caption>
          <p>
            <bold>Scale for methodological quality assessment.</bold>
          </p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pone.0030585.s005" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pone.0030585.s005" xlink:type="simple">
        <label>Table S3</label>
        <caption>
          <p>
            <bold>Heterogeneity test.</bold>
          </p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pone.0030585.s006" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pone.0030585.s006" xlink:type="simple">
        <label>Table S4</label>
        <caption>
          <p>
            <bold>ORs (95% CI) of sensitivity analysis.</bold>
          </p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pone.0030585.s007" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pone.0030585.s007" xlink:type="simple">
        <label>Table S5</label>
        <caption>
          <p>
            <bold>MOOSE Checklist.</bold>
          </p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack>
      <p>We thank Qingyi Wei and Zhensheng Liu from the University of Texas MD Anderson Cancer Center, Karl T. Kelsey from the Department of Pathology and Laboratory Medicine, Brown University, for generously providing their unpublished data. We also thank Xiang Shu from the School of Public Health, University of Texas Health Science Center, for critiquing and editing the paper.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="pone.0030585-Bartel1">
        <label>1</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Bartel</surname><given-names>DP</given-names></name><name name-style="western"><surname>Chen</surname><given-names>CZ</given-names></name></person-group>             <year>2004</year>             <article-title>Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs.</article-title>             <source>Nat Rev Genet</source>             <volume>5</volume>             <fpage>396</fpage>             <lpage>400</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Bartel2">
        <label>2</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Bartel</surname><given-names>DP</given-names></name></person-group>             <year>2004</year>             <article-title>MicroRNAs: genomics, biogenesis, mechanism, and function.</article-title>             <source>Cell</source>             <volume>116</volume>             <fpage>281</fpage>             <lpage>297</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Landi1">
        <label>3</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Landi</surname><given-names>D</given-names></name><name name-style="western"><surname>Gemignani</surname><given-names>F</given-names></name><name name-style="western"><surname>Naccarati</surname><given-names>A</given-names></name><name name-style="western"><surname>Pardini</surname><given-names>B</given-names></name><name name-style="western"><surname>Vodicka</surname><given-names>P</given-names></name><etal/></person-group>             <year>2008</year>             <article-title>Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer.</article-title>             <source>Carcinogenesis</source>             <volume>29</volume>             <fpage>579</fpage>             <lpage>584</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Carthew1">
        <label>4</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Carthew</surname><given-names>RW</given-names></name></person-group>             <year>2006</year>             <article-title>Gene regulation by microRNAs.</article-title>             <source>Curr Opin Genet Dev</source>             <volume>16</volume>             <fpage>203</fpage>             <lpage>208</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Kent1">
        <label>5</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Kent</surname><given-names>OA</given-names></name><name name-style="western"><surname>Mendell</surname><given-names>JT</given-names></name></person-group>             <year>2006</year>             <article-title>A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes.</article-title>             <source>Oncogene</source>             <volume>25</volume>             <fpage>6188</fpage>             <lpage>6196</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Hu1">
        <label>6</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Tian</surname><given-names>T</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X</given-names></name><name name-style="western"><surname>Gu</surname><given-names>H</given-names></name><etal/></person-group>             <year>2008</year>             <article-title>Genetic variants of miRNA sequences and non-small cell lung cancer survival.</article-title>             <source>J Clin Invest</source>             <volume>118</volume>             <fpage>2600</fpage>             <lpage>2608</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Pineau1">
        <label>7</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Pineau</surname><given-names>P</given-names></name><name name-style="western"><surname>Volinia</surname><given-names>S</given-names></name><name name-style="western"><surname>McJunkin</surname><given-names>K</given-names></name><name name-style="western"><surname>Marchio</surname><given-names>A</given-names></name><name name-style="western"><surname>Battiston</surname><given-names>C</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>miR-221 overexpression contributes to liver tumorigenesis.</article-title>             <source>Proc Natl Acad Sci U S A</source>             <volume>107</volume>             <fpage>264</fpage>             <lpage>269</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Chen1">
        <label>8</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>K</given-names></name><name name-style="western"><surname>Song</surname><given-names>F</given-names></name><name name-style="western"><surname>Calin</surname><given-names>GA</given-names></name><name name-style="western"><surname>Wei</surname><given-names>Q</given-names></name><name name-style="western"><surname>Hao</surname><given-names>X</given-names></name><etal/></person-group>             <year>2008</year>             <article-title>Polymorphisms in microRNA targets: a gold mine for molecular epidemiology.</article-title>             <source>Carcinogenesis</source>             <volume>29</volume>             <fpage>1306</fpage>             <lpage>1311</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Chu1">
        <label>9</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Chu</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M</given-names></name><name name-style="western"><surname>Shi</surname><given-names>D</given-names></name><name name-style="western"><surname>Ma</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name><etal/></person-group>             <year>2011</year>             <article-title>Hsa-miR-196a2 Rs11614913 polymorphism contributes to cancer susceptibility: evidence from 15 case-control studies.</article-title>             <source>PLoS One</source>             <volume>6</volume>             <fpage>e18108</fpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Gao1">
        <label>10</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>LB</given-names></name><name name-style="western"><surname>Bai</surname><given-names>P</given-names></name><name name-style="western"><surname>Pan</surname><given-names>XM</given-names></name><name name-style="western"><surname>Jia</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>LJ</given-names></name><etal/></person-group>             <year>2011</year>             <article-title>The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis.</article-title>             <source>Breast Cancer Res Treat</source>             <volume>125</volume>             <fpage>571</fpage>             <lpage>574</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Tian1">
        <label>11</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Tian</surname><given-names>T</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Dai</surname><given-names>J</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J</given-names></name><name name-style="western"><surname>Shen</surname><given-names>H</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>Functional polymorphisms in two pre-microRNAs and cancer risk: a meta-analysis.</article-title>             <source>Int J Mol Epidemiol Genet</source>             <volume>1</volume>             <fpage>358</fpage>             <lpage>366</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Wang1">
        <label>12</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>F</given-names></name><name name-style="western"><surname>Ma</surname><given-names>YL</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>P</given-names></name><name name-style="western"><surname>Yang</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Chen</surname><given-names>HQ</given-names></name><etal/></person-group>             <year>2011</year>             <article-title>A genetic variant in microRNA-196a2 is associated with increased cancer risk: a meta-analysis.</article-title>             <source>Mol Biol Rep</source>          </element-citation>
      </ref>
      <ref id="pone.0030585-Xu1">
        <label>13</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>W</given-names></name><name name-style="western"><surname>Xu</surname><given-names>J</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S</given-names></name><name name-style="western"><surname>Chen</surname><given-names>B</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><etal/></person-group>             <year>2011</year>             <article-title>Effects of common polymorphisms rs11614913 in miR-196a2 and rs2910164 in miR-146a on cancer susceptibility: a meta-analysis.</article-title>             <source>PLoS One</source>             <volume>6</volume>             <fpage>e20471</fpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Chen2">
        <label>14</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>H</given-names></name><name name-style="western"><surname>Sun</surname><given-names>LY</given-names></name><name name-style="western"><surname>Chen</surname><given-names>LL</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>HQ</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>QF</given-names></name></person-group>             <year>2011</year>             <article-title>A variant in microRNA-196a2 is not associated with susceptibility to and progression of colorectal cancer in Chinese.</article-title>             <source>Intern Med J</source>          </element-citation>
      </ref>
      <ref id="pone.0030585-Zhan1">
        <label>15</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Zhan</surname><given-names>JF</given-names></name><name name-style="western"><surname>Chen</surname><given-names>LH</given-names></name><name name-style="western"><surname>Chen</surname><given-names>ZX</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>YW</given-names></name><name name-style="western"><surname>Xie</surname><given-names>GZ</given-names></name><etal/></person-group>             <year>2011</year>             <article-title>A functional variant in microRNA-196a2 is associated with susceptibility of colorectal cancer in a Chinese population.</article-title>             <source>Arch Med Res</source>             <volume>42</volume>             <fpage>144</fpage>             <lpage>148</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Zhu1">
        <label>16</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>L</given-names></name><name name-style="western"><surname>Chu</surname><given-names>H</given-names></name><name name-style="western"><surname>Gu</surname><given-names>D</given-names></name><name name-style="western"><surname>Ma</surname><given-names>L</given-names></name><name name-style="western"><surname>Shi</surname><given-names>D</given-names></name><etal/></person-group>             <year>2011</year>             <article-title>A Functional Polymorphism in miRNA-196a2 Is Associated with Colorectal Cancer Risk in a Chinese Population.</article-title>             <source>DNA Cell Biol</source>          </element-citation>
      </ref>
      <ref id="pone.0030585-Akkiz1">
        <label>17</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Akkiz</surname><given-names>H</given-names></name><name name-style="western"><surname>Bayram</surname><given-names>S</given-names></name><name name-style="western"><surname>Bekar</surname><given-names>A</given-names></name><name name-style="western"><surname>Akgollu</surname><given-names>E</given-names></name><name name-style="western"><surname>Ulger</surname><given-names>Y</given-names></name></person-group>             <year>2011</year>             <article-title>A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study.</article-title>             <source>J Viral Hepat</source>             <volume>18</volume>             <fpage>e399</fpage>             <lpage>407</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Christensen1">
        <label>18</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Christensen</surname><given-names>BC</given-names></name><name name-style="western"><surname>Avissar-Whiting</surname><given-names>M</given-names></name><name name-style="western"><surname>Ouellet</surname><given-names>LG</given-names></name><name name-style="western"><surname>Butler</surname><given-names>RA</given-names></name><name name-style="western"><surname>Nelson</surname><given-names>HH</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>Mature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer.</article-title>             <source>Clin Cancer Res</source>             <volume>16</volume>             <fpage>3713</fpage>             <lpage>3720</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Liu1">
        <label>19</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Li</surname><given-names>G</given-names></name><name name-style="western"><surname>Wei</surname><given-names>S</given-names></name><name name-style="western"><surname>Niu</surname><given-names>J</given-names></name><name name-style="western"><surname>El-Naggar</surname><given-names>AK</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck.</article-title>             <source>Cancer</source>             <volume>116</volume>             <fpage>4753</fpage>             <lpage>4760</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Thakkinstian1">
        <label>20</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Thakkinstian</surname><given-names>A</given-names></name><name name-style="western"><surname>McEvoy</surname><given-names>M</given-names></name><name name-style="western"><surname>Minelli</surname><given-names>C</given-names></name><name name-style="western"><surname>Gibson</surname><given-names>P</given-names></name><name name-style="western"><surname>Hancox</surname><given-names>B</given-names></name><etal/></person-group>             <year>2005</year>             <article-title>Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: a HuGE review.</article-title>             <source>Am J Epidemiol</source>             <volume>162</volume>             <fpage>201</fpage>             <lpage>211</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Camargo1">
        <label>21</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Camargo</surname><given-names>MC</given-names></name><name name-style="western"><surname>Mera</surname><given-names>R</given-names></name><name name-style="western"><surname>Correa</surname><given-names>P</given-names></name><name name-style="western"><surname>Peek</surname><given-names>RM</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Fontham</surname><given-names>ET</given-names></name><etal/></person-group>             <year>2006</year>             <article-title>Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis.</article-title>             <source>Cancer Epidemiol Biomarkers Prev</source>             <volume>15</volume>             <fpage>1674</fpage>             <lpage>1687</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Gao2">
        <label>22</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>LB</given-names></name><name name-style="western"><surname>Pan</surname><given-names>XM</given-names></name><name name-style="western"><surname>Li</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Liang</surname><given-names>WB</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name><etal/></person-group>             <year>2011</year>             <article-title>RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies.</article-title>             <source>Breast Cancer Res Treat</source>             <volume>125</volume>             <fpage>827</fpage>             <lpage>835</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Higgins1">
        <label>23</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Higgins</surname><given-names>JP</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>SG</given-names></name></person-group>             <year>2002</year>             <article-title>Quantifying heterogeneity in a meta-analysis.</article-title>             <source>Stat Med</source>             <volume>21</volume>             <fpage>1539</fpage>             <lpage>1558</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Higgins2">
        <label>24</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Higgins</surname><given-names>JP</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>SG</given-names></name><name name-style="western"><surname>Deeks</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Altman</surname><given-names>DG</given-names></name></person-group>             <year>2003</year>             <article-title>Measuring inconsistency in meta-analyses.</article-title>             <source>BMJ</source>             <volume>327</volume>             <fpage>557</fpage>             <lpage>560</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-DerSimonian1">
        <label>25</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>DerSimonian</surname><given-names>R</given-names></name><name name-style="western"><surname>Laird</surname><given-names>N</given-names></name></person-group>             <year>1986</year>             <article-title>Meta-analysis in clinical trials.</article-title>             <source>Control Clin Trials</source>             <volume>7</volume>             <fpage>177</fpage>             <lpage>188</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Mantel1">
        <label>26</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Mantel</surname><given-names>N</given-names></name><name name-style="western"><surname>Haenszel</surname><given-names>W</given-names></name></person-group>             <year>1959</year>             <article-title>Statistical aspects of the analysis of data from retrospective studies of disease.</article-title>             <source>J Natl Cancer Inst</source>             <volume>22</volume>             <fpage>719</fpage>             <lpage>748</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Hayashino1">
        <label>27</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Hayashino</surname><given-names>Y</given-names></name><name name-style="western"><surname>Noguchi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Fukui</surname><given-names>T</given-names></name></person-group>             <year>2005</year>             <article-title>Systematic evaluation and comparison of statistical tests for publication bias.</article-title>             <source>J Epidemiol</source>             <volume>15</volume>             <fpage>235</fpage>             <lpage>243</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Peters1">
        <label>28</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Peters</surname><given-names>JL</given-names></name><name name-style="western"><surname>Sutton</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Jones</surname><given-names>DR</given-names></name><name name-style="western"><surname>Abrams</surname><given-names>KR</given-names></name><name name-style="western"><surname>Rushton</surname><given-names>L</given-names></name></person-group>             <year>2006</year>             <article-title>Comparison of two methods to detect publication bias in meta-analysis.</article-title>             <source>JAMA</source>             <volume>295</volume>             <fpage>676</fpage>             <lpage>680</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Begg1">
        <label>29</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Begg</surname><given-names>CB</given-names></name><name name-style="western"><surname>Mazumdar</surname><given-names>M</given-names></name></person-group>             <year>1994</year>             <article-title>Operating characteristics of a rank correlation test for publication bias.</article-title>             <source>Biometrics</source>             <volume>50</volume>             <fpage>1088</fpage>             <lpage>1101</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Li1">
        <label>30</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>XD</given-names></name><name name-style="western"><surname>Li</surname><given-names>ZG</given-names></name><name name-style="western"><surname>Song</surname><given-names>XX</given-names></name><name name-style="western"><surname>Liu</surname><given-names>CF</given-names></name></person-group>             <year>2010</year>             <article-title>A variant in microRNA-196a2 is associated with susceptibility to hepatocellular carcinoma in Chinese patients with cirrhosis.</article-title>             <source>Pathology</source>             <volume>42</volume>             <fpage>669</fpage>             <lpage>673</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Okubo1">
        <label>31</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Okubo</surname><given-names>M</given-names></name><name name-style="western"><surname>Tahara</surname><given-names>T</given-names></name><name name-style="western"><surname>Shibata</surname><given-names>T</given-names></name><name name-style="western"><surname>Yamashita</surname><given-names>H</given-names></name><name name-style="western"><surname>Nakamura</surname><given-names>M</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>Association between common genetic variants in pre-microRNAs and gastric cancer risk in Japanese population.</article-title>             <source>Helicobacter</source>             <volume>15</volume>             <fpage>524</fpage>             <lpage>531</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Peng1">
        <label>32</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Peng</surname><given-names>S</given-names></name><name name-style="western"><surname>Kuang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Sheng</surname><given-names>C</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xu</surname><given-names>H</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>Association of microRNA-196a-2 gene polymorphism with gastric cancer risk in a Chinese population.</article-title>             <source>Dig Dis Sci</source>             <volume>55</volume>             <fpage>2288</fpage>             <lpage>2293</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Qi1">
        <label>33</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Qi</surname><given-names>P</given-names></name><name name-style="western"><surname>Dou</surname><given-names>TH</given-names></name><name name-style="western"><surname>Geng</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>FG</given-names></name><name name-style="western"><surname>Gu</surname><given-names>X</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection.</article-title>             <source>Hum Immunol</source>             <volume>71</volume>             <fpage>621</fpage>             <lpage>626</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Srivastava1">
        <label>34</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Srivastava</surname><given-names>K</given-names></name><name name-style="western"><surname>Srivastava</surname><given-names>A</given-names></name><name name-style="western"><surname>Mittal</surname><given-names>B</given-names></name></person-group>             <year>2010</year>             <article-title>Common genetic variants in pre-microRNAs and risk of gallbladder cancer in North Indian population.</article-title>             <source>J Hum Genet</source>             <volume>55</volume>             <fpage>495</fpage>             <lpage>499</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Wang2">
        <label>35</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>K</given-names></name><name name-style="western"><surname>Guo</surname><given-names>H</given-names></name><name name-style="western"><surname>Hu</surname><given-names>H</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>G</given-names></name><name name-style="western"><surname>Guan</surname><given-names>X</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>A functional variation in pre-microRNA-196a is associated with susceptibility of esophageal squamous cell carcinoma risk in Chinese Han.</article-title>             <source>Biomarkers</source>             <volume>15</volume>             <fpage>614</fpage>             <lpage>618</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Hong1">
        <label>36</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Hong</surname><given-names>YS</given-names></name><name name-style="western"><surname>Kang</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Kwak</surname><given-names>JY</given-names></name><name name-style="western"><surname>Park</surname><given-names>BL</given-names></name><name name-style="western"><surname>You</surname><given-names>CH</given-names></name><etal/></person-group>             <year>2011</year>             <article-title>Association between microRNA196a2 rs11614913 genotypes and the risk of non-small cell lung cancer in Korean population.</article-title>             <source>J Prev Med Public Health</source>             <volume>44</volume>             <fpage>125</fpage>             <lpage>130</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Hu2">
        <label>37</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Liang</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Tian</surname><given-names>T</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women.</article-title>             <source>Hum Mutat</source>             <volume>30</volume>             <fpage>79</fpage>             <lpage>84</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Dou1">
        <label>38</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Dou</surname><given-names>T</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Q</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><name name-style="western"><surname>Ribas</surname><given-names>J</given-names></name><name name-style="western"><surname>Ni</surname><given-names>X</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>A polymorphism of microRNA196a genome region was associated with decreased risk of glioma in Chinese population.</article-title>             <source>J Cancer Res Clin Oncol</source>             <volume>136</volume>             <fpage>1853</fpage>             <lpage>1859</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-George1">
        <label>39</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>George</surname><given-names>GP</given-names></name><name name-style="western"><surname>Gangwar</surname><given-names>R</given-names></name><name name-style="western"><surname>Mandal</surname><given-names>RK</given-names></name><name name-style="western"><surname>Sankhwar</surname><given-names>SN</given-names></name><name name-style="western"><surname>Mittal</surname><given-names>RD</given-names></name></person-group>             <year>2011</year>             <article-title>Genetic variation in microRNA genes and prostate cancer risk in North Indian population.</article-title>             <source>Mol Biol Rep</source>             <volume>38</volume>             <fpage>1609</fpage>             <lpage>1615</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Yu1">
        <label>40</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name><name name-style="western"><surname>Jolicoeur</surname><given-names>N</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Fortin</surname><given-names>Y</given-names></name><etal/></person-group>             <year>2007</year>             <article-title>Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers.</article-title>             <source>Nucleic Acids Res</source>             <volume>35</volume>             <fpage>4535</fpage>             <lpage>4541</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Tapia1">
        <label>41</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Tapia</surname><given-names>T</given-names></name><name name-style="western"><surname>Sanchez</surname><given-names>A</given-names></name><name name-style="western"><surname>Vallejos</surname><given-names>M</given-names></name><name name-style="western"><surname>Alvarez</surname><given-names>C</given-names></name><name name-style="western"><surname>Moraga</surname><given-names>M</given-names></name><etal/></person-group>             <year>2008</year>             <article-title>ATM allelic variants associated to hereditary breast cancer in 94 Chilean women: susceptibility or ethnic influences?</article-title>             <source>Breast Cancer Res Treat</source>             <volume>107</volume>             <fpage>281</fpage>             <lpage>288</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Dick1">
        <label>42</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Dick</surname><given-names>DM</given-names></name></person-group>             <year>2011</year>             <article-title>Gene-environment interaction in psychological traits and disorders.</article-title>             <source>Annu Rev Clin Psychol</source>             <volume>7</volume>             <fpage>383</fpage>             <lpage>409</lpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Gao3">
        <label>43</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>LB</given-names></name><name name-style="western"><surname>Pan</surname><given-names>XM</given-names></name><name name-style="western"><surname>Sun</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Rao</surname><given-names>L</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>The association between ATM D1853N polymorphism and breast cancer susceptibility: a meta-analysis.</article-title>             <source>J Exp Clin Cancer Res</source>             <volume>29</volume>             <fpage>117</fpage>          </element-citation>
      </ref>
      <ref id="pone.0030585-Wallace1">
        <label>44</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Wallace</surname><given-names>TA</given-names></name><name name-style="western"><surname>Martin</surname><given-names>DN</given-names></name><name name-style="western"><surname>Ambs</surname><given-names>S</given-names></name></person-group>             <year>2011</year>             <article-title>Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scale.</article-title>             <source>Carcinogenesis</source>             <volume>32</volume>             <fpage>1107</fpage>             <lpage>1121</lpage>          </element-citation>
      </ref>
    </ref-list>
    
  </back>
</article>